SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-24-000739
Filing Date
2024-05-15
Accepted
2024-05-15 16:30:37
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cdio_10q-033124.htm   iXBRL 10-Q 717029
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 7958
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 8091
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 4256
5 EXHIBIT 32.2 ex32x2.htm EX-32.2 4340
  Complete submission text file 0001079973-24-000739.txt   4511602

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdio-20240331.xsd EX-101.SCH 45694
7 XBRL CALCULATION FILE cdio-20240331_cal.xml EX-101.CAL 50372
8 XBRL DEFINITION FILE cdio-20240331_def.xml EX-101.DEF 165480
9 XBRL LABEL FILE cdio-20240331_lab.xml EX-101.LAB 339527
10 XBRL PRESENTATION FILE cdio-20240331_pre.xml EX-101.PRE 282898
77 EXTRACTED XBRL INSTANCE DOCUMENT cdio_10q-033124_htm.xml XML 511191
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

IRS No.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41097 | Film No.: 24951490
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)